Skip to main content
NewslettersWatchlist

Vivos Therapeutics Inc(VVOS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low2.23
Day High2.34
Open:2.29
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
AllPennyStocks.com
Biotech Soars On New Agreements
Spotlight Growth
Vivos Therapeutics (NASDAQ: VVOS) Secures Strategic Alliances to Enhance Clear Aligner Offerings and Bolster Revenue Streams
Business Wire
Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for Its Entire Line of Oral Appliances
Globe Newswire
Vivos Therapeutics’ SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep Apnea
Globe Newswire
Vivos Therapeutics Schedules First Quarter 2022 Financial Results Conference Call
Globe Newswire
Vivos Therapeutics Opens Third U.S. Multidisciplinary Center to Treat Patients Suffering from Sleep Apnea with The Vivos Method
Globe Newswire
Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
Globe Newswire
Vivos Therapeutics Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call
Globe Newswire
Fast Company Selects Vivos Therapeutics for 2022 “World’s Most Innovative Companies” List
Globe Newswire
Vivos Therapeutics to Participate in Upcoming Investor Conferences
Globe Newswire
Vivos Therapeutics Files for US Patent on Proprietary New Clinical Protocols After Seeing Further Significant Improvement in Reduction of Key Sleep Apnea Metric
Globe Newswire
Vivos Therapeutics Announces 18X Increase in Sleep Apnea Diagnostic Testing By Vivos Dentists Using SleepImage Technology
Globe Newswire
Vivos Therapeutics’ mmRNA Oral Appliance Now Eligible for Medicare Reimbursement
Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Officially Registers with Health Canada
Globe Newswire
Vivos Therapeutics Announces Registration with Health Canada to Manufacture and Sell Sleep Disorder, Snoring and Sleep Apnea Appliances to Canadian Dentists
Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Global Small Cap Conference
Globe Newswire
Vivos Therapeutics to Participate at the Benzinga Global Small Cap Conference
Investor Brand Network
New Study Backs Benefits of CPAP Therapy for OSA
Investor Brand Network
Study Explores Link Between Obstructive Sleep Apnea and COVID-19
Investor Brand Network
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q3 2021 Financial, Operational Report
Globe Newswire
Vivos Therapeutics Reports Third Quarter 2021 Financial Results and Operational Update
Investor Brand Network
Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies
Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation at Q4 Virtual Investor Summit
Globe Newswire
Vivos Therapeutics to Participate at the Q4 Virtual Investor Summit
Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Scheduled Release of Q3 2021 Financial Results, Conference Call
Investor Brand Network
Study Finds High Triglyceride Levels May Be Linked to Obstructive Sleep Apnea
Investor Brand Network
Obstructive Sleep Apnea May Be Affecting Productivity in Workplace
Investor Brand Network
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Global Small Cap Conference
Globe Newswire
Vivos Therapeutics to Participate at the Benzinga Global Small Cap Conference
Investor Brand Network
OSA Predisposes People to Metabolic Defects, Study Finds
Investor Brand Network
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Showcasing Innovations in OSA Treatment at 2021 Annual Breathing Wellness Conference
Globe Newswire
Vivos Therapeutics Announces 2021 Annual Breathing Wellness Conference Presented by The Vivos Institute

Profile

Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.